SEBI vs Jane Street: A Landmark Crackdown on Expiry-Day Manipulation

In a bold and unprecedented move, the Securities and Exchange Board of India (SEBI) has taken decisive action against global quant trading firm Jane Street for alleged manipulation of expiry-day trades in India's equity derivatives market. This move not only underscores SEBI’s commitment to preserving market integrity but also serves as a cautionary tale for institutional players operating in India’s rapidly maturing financial ecosystem.

What Is Expiry-Day Manipulation?

In the derivatives market, “expiry day” refers to the day on which futures and options contracts expire—typically the last Thursday of the month (or every Thursday for weekly options). On these days, minor price fluctuations in underlying stocks can lead to massive gains or losses in options positions.

According to SEBI, Jane Street exploited this by:

• Aggressively buying index-heavyweight stocks in the morning, pushing up the Nifty and Bank Nifty indices

• Simultaneously holding large options positions designed to benefit from such index movement

• Squaring off both positions in the afternoon to lock in significant profits

This practice, while algorithmically complex, allegedly distorted price discovery, created artificial volatility, and disadvantaged retail and smaller institutional participants.

SEBI’s Allegations and Action

On July 3, 2025, SEBI passed an interim order that:

• Bans Jane Street and its affiliates from accessing Indian securities markets

• Freezes alleged unlawful gains of over ₹4,840 crore (~$570 million)

• Gives the firm 21 days to respond or appeal to the Securities Appellate Tribunal (SAT)

This action is based on evidence collected over a 15-month investigation period, starting April 2024, including trading patterns, internal correspondence, and prior warnings issued by the regulator.

Market Reactions

The Indian trading community has responded positively. Domestic proprietary traders and long-term investors have hailed SEBI’s crackdown, arguing that expiry-day volatility had reached unhealthy levels, deterring genuine participation.

SEBI’s move is also being seen as a clear signal to foreign institutional investors (FIIs) that India welcomes participation, but not at the cost of market fairness or regulatory defiance.

Broader Implications

1. Strengthened Surveillance

SEBI has shown that it is not afraid to confront the most sophisticated global players. Expect more real-time surveillance tools and data-driven enforcement in the future.

2. Tighter Rules Ahead

This incident may lead to reforms in options market structure, including limits on open interest, stricter position disclosures, or tighter rules around expiry-day behavior.

3. Global Attention

This case has caught the eye of regulators worldwide. As Indian markets become more integrated with global finance, this action enhances India's reputation for robust regulatory oversight.

What This Means for You

Whether you're a retail investor, portfolio manager, or compliance officer, this case is a reminder of the following:

• Transparency matters. Regulatory evasion—even by sophisticated firms—won’t go unnoticed.

• Expiry-day volatility is not a coincidence. Be cautious with options trading, especially around settlement periods.

• India is no longer a soft regulatory market. Expect heightened scrutiny, especially for algorithmic and high-frequency trading (HFT) strategies.

• 
  

Conclusion

SEBI’s interim order against Jane Street is not just a headline—it’s a landmark enforcement action that could reshape India’s derivatives market in the months to come. At Infosential LLP, we are closely tracking these developments and advising clients on risk, compliance, and trading strategies in light of the new regulatory environment.

If you or your firm deal in F&O markets, now is the time to review internal controls, algo trading logic, and expiry-day exposure.

Need help navigating SEBI’s evolving compliance landscape?

Contact Infosential LLP – Your Partner in Finance, Tax & Regulatory Strategy.